4//SEC Filing
Eisenberg Or 4
Accession 0001213900-18-005270
CIK 0001218683other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 11:27 AM ET
Size
7.4 KB
Accession
0001213900-18-005270
Insider Transaction Report
Form 4
Eisenberg Or
Acting CEO, CFO, Treas & Secy.
Transactions
- Award
Restricted Stock Units (RSU)
2018-04-04+40,100→ 40,100 total - Award
Stock Option (right to buy)
2018-04-04+36,000→ 0 totalExercise: $3.59Exp: 2025-04-04→ Common Stock (36,000 underlying)
Footnotes (4)
- [F1]The RSUs were fully vested upon grant.
- [F2]The RSUs were granted as compensation for services as the CEO of the Issuer.
- [F3]The Stock Option is exercisable in twelve equal installments over the three year period from the date of grant.
- [F4]The Stock Option was granted as compensation for services as the CEO of the Issuer.
Documents
Issuer
Wize Pharma, Inc.
CIK 0001218683
Entity typeother
Related Parties
1- filerCIK 0001721412
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 11:27 AM ET
- Size
- 7.4 KB